Patients need the appropriate ongoing wraparound support to unlock the health benefits of GLP-1s without the adverse impacts, and healthcare buyers need solutions that help them manage costs while ensuring their members and employees have what they need to get and stay healthy
Cardiovascular safety trials for all new diabetes mellitus drugs
Ozempic, Mounjaro, and Generic Liraglutide are FDA-approved for type 2 diabetes treatment but may also be prescribed for weight loss at a healthcare providers discretion
The average starting weight was 108.7 kg, with a mean BMI of 37.9
a - f , Treatment of C57BL/6 J DIO mice with once-daily subcutaneous (s.c.) injections of 900 nmol kg 1 MK-801 (n = 8 mice and n = 4 cages), 1800 nmol kg 1 MK-801 (n = 6 mice and n = 3 cages) or vehicle (isotonic saline, n = 7 mice and n = 3 cages) over 7 days
Download the bulletin for more details.